Vivos Therapeutics
Quarterly Financials
| Values in thousands | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 |
|---|---|---|---|---|
Revenue | $5,153 | $5,141 | $3,824 | $6,783 |
Gross Profit | 2,953 | 2,605 | 2,988 | 3,937 |
EBITDA | -4,423 | -7,297 | -5,016 | |
EBIT | -5,523 | -7,751 | -5,400 | |
Net Income | -5,481 | -7,751 | -6,954 | -5,400 |
Net Change In Cash | 5,153 | 5,141 | 3,824 | 6,783 |
Free Cash Flow | -3,130 | -6,010 | -5,343 | -4,078 |
Cash | 1,774 | 2,110 | 2,029 | 3,087 |
Basic Shares | 17,681 | 14,634 | 9,286 | 10,963 |
Annual Financials
| Values in thousands | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
Revenue | $17,443 | $15,031 | $13,801 | $16,024 |
Gross Profit | 10,542 | 9,019 | 8,271 | 10,019 |
EBITDA | -19,921 | -10,555 | -12,962 | -23,176 |
EBIT | -21,230 | -11,136 | -13,583 | -23,845 |
Net Income | -21,230 | -11,136 | -13,583 | -23,845 |
Net Change In Cash | 17,443 | 15,031 | 13,801 | 16,024 |
Free Cash Flow | -17,604 | -13,259 | -12,749 | -20,511 |
Cash | 2,029 | 6,260 | 1,643 | 3,519 |
Basic Shares | 10,273 | 5,019 | 1,219 | 920 |
Earnings Calls
| Quarter | EPS |
|---|---|
2026-06-30 | -$0.31 |
2026-03-31 | -$0.52 |
2025-12-31 | -$0.58 |
2025-09-30 | -$0.49 |